PSNL News
Are VRNS, DSGR, PSNL Obtaining Fair Deals for their Shareholders?
Are VRNS, DSGR, PSNL Obtaining Fair Deals for their Shareholders? Are VRNS, DSGR, PSNL Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 22, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire
Are VRNS, DSGR, PSNL Obtaining Fair Deals for their Shareholders?
Are VRNS, DSGR, PSNL Obtaining Fair Deals for their Shareholders? Are VRNS, DSGR, PSNL Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 22, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire
PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced Investors are Alerted to Contact BFA Law
Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc. Personalis is incorporated in Delaware.If you are a current stockholder of Personalis, you are...
Business Wire
Personalis NeXT Personal Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that two oral presentations and two poster presentations featuring its NeXT Personal ultrasensitive circulating tumor DNA (ctDNA) test will be presented at the European Society for Medical...
Business Wire
Personalis Brings Resistance Mutation Tracking to NeXT Personal MRD Test
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the commercial launch of optional Real-Time Variant Tracker supplemental results in the NeXT Personal molecular residual disease (MRD) test report. These results identify clinically relevant resistance and...
Business Wire
Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
The trades put some of Ark's better-known holdings on the sell side, including AMD, Alphabet, and SpaceX, while its genomics-focused ARK Genomic Revolution ETF continued to add to biotech companies.
This Gentex Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
Analysts downgraded Gentex, Personalis, Goosehead Insurance, cutting ratings and several price targets.read more...
Benzinga
Are MKTX, HOWL, PSNL Obtaining Fair Deals for their Shareholders?
Are MKTX, HOWL, PSNL Obtaining Fair Deals for their Shareholders? Are MKTX, HOWL, PSNL Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Sept. 9, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire
Are PSNL, MKTX, BZH, HOWL Obtaining Fair Deals for their Shareholders?
Are PSNL, MKTX, BZH, HOWL Obtaining Fair Deals for their Shareholders? Are PSNL, MKTX, BZH, HOWL Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Sept. 4, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...
PR Newswire
What's Going On With Tempus AI Stock on Monday?
Tempus AI stock pulls back after a 20% surge as cancer data spotlights its Personalis deal, and FDA clears its pulmonary hypertension AI tool.read more...
Benzinga